ICD-10-PCS Billable Code

075J4ZZ

Destruction Lymphatic, Left Inguinal to No Qualifier with No Device, Percutaneous Endoscopic Approach

Procedural Specifications

Clinical Axis Detail Definition
Section0 Medical and Surgical
Body System7 Lymphatic and Hemic Systems
Operation5 Destruction
Body PartJ Lymphatic, Left Inguinal
Approach4 Percutaneous Endoscopic
DeviceZ No Device
QualifierZ No Qualifier

Operation Definition

Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent

Procedure Overview

Destruction procedures in the lymphatic and hemic systems eliminate abnormal tissue in place, using heat, cold, chemicals, or other energy sources rather than physically cutting it out. In practice this most often means sclerotherapy or ablation of lymphatic malformations, cystic hygromas, or enlarged lymph nodes, where injecting or applying an agent causes the abnormal tissue to shrink and scar down.

This approach is favored when surgical removal would be difficult or risky, such as malformations located near major blood vessels or nerves, or in children where minimizing surgical trauma matters. It can also be used to manage lymphoceles that have not responded to simple drainage.

Because the tissue is destroyed rather than removed, there is nothing sent to pathology, which is a key practical difference from excisional approaches.

Anatomy & Axis Detail

Lymphatic, Left Inguinal

Left inguinal lymph nodes lie in the groin along the femoral sheath, collecting lymph from the left leg, external genitalia, and lower abdominal wall, and are frequently involved by melanoma, vulvar, or lower-extremity malignancies as well as inflammatory conditions. When the abnormal nodal tissue is destroyed in place rather than surgically dissected out, energy-based ablation is applied directly to the nodes, sparing the patient the extensive dissection and lymphedema risk associated with complete inguinal lymphadenectomy. The femoral vessels and saphenous vein course close by, so imaging guidance is common. Documentation should specify left-sided involvement and confirm that the procedure was ablative rather than excisional or resective in nature.

Approach: Percutaneous Endoscopic

Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.

Coding & Documentation

Coders should assign Destruction when the documentation describes obliterating tissue in place, through sclerosing agents, laser, radiofrequency, or similar means, with no specimen extracted from the body. The specific agent or energy source used should be reflected in the approach and, where applicable, the qualifier.

A common error is coding a sclerotherapy injection as Introduction of a substance rather than Destruction of the target tissue, since both involve injecting an agent but only one is aimed at eradicating the lymphatic structure itself. Reviewing physician intent and the described tissue effect, rather than just the act of injection, resolves this distinction.

Commonly Confused With

ExcisionDestruction is often confused with Excision, since both can address an abnormal lymphatic mass; the deciding factor is whether tissue is physically removed and sent to pathology (Excision) versus eradicated in place with no specimen (Destruction).
IntroductionIt also overlaps with Introduction when a substance is instilled, differentiated by whether the goal is chemical delivery or tissue eradication.